Unique ID issued by UMIN | UMIN000018850 |
---|---|
Receipt number | R000021804 |
Scientific Title | A randomized controlled trial comparing continuous femoral nerve block and local infiltration analgesiafor total knee arthroplasty |
Date of disclosure of the study information | 2015/08/29 |
Last modified on | 2016/04/02 18:00:53 |
A randomized controlled trial comparing continuous femoral nerve block and local infiltration analgesiafor total knee arthroplasty
A randomized controlled trial comparing continuous femoral nerve block and local infiltration analgesiafor total knee arthroplasty
A randomized controlled trial comparing continuous femoral nerve block and local infiltration analgesiafor total knee arthroplasty
A randomized controlled trial comparing continuous femoral nerve block and local infiltration analgesiafor total knee arthroplasty
Japan |
Osteoarthritis of knee
Orthopedics |
Others
NO
To compare the continuous femoral nerve block and local infiltration analgesia for pain after total knee arthroplasty.
Safety,Efficacy
Visual analog scale score at rest at 1 day after surgery.
The postoperative visual analog scale score at rest other than at the 1 day.
Total amount of morphine consumption.
Post operative labo date.
Post operative complication.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine | Maneuver |
A continuous femoral nerve block for pain after total knee arthroplasty (total of 20 ml of 2.0 mg / ml of ropivacaine was injected around the femoral nerve as an initial block. Postoperatively, 1.5 mg / mL of ropivacaine was continuously infused at the rate of 5 mL per hour for 48 hours through the catheter).
A local infiltration analgesia for pain after total knee arthroplasty (7.5 mg / ml of ropivacaine [40 mL], 100mg of ketoprofen [5 mL ], 1 mg / ml of epinephrine [0.5 mL] and 40 ml of normal saline).
60 | years-old | <= |
85 | years-old | >= |
Male and Female
Patients scheduled for primary unilateral total knee arthroplasty.
History of allergy or intolerance to one of the study drugs, serious internal co-morbidities, chronic inflammatory joint disease (i.e. rheumatoid arthritis), or bleeding disorder.
40
1st name | |
Middle name | |
Last name | Shinichi Yoshiya |
Hyogo College of Medicine
Orthopaedic surgery
663-8501 1-1 Mukogawa-cho, Nishinomiya City, Hyogo, Japan
0798-45-6111
yoshiya@hyo-med.ac.jp
1st name | |
Middle name | |
Last name | Kenji Kurosaka |
Hyogo College of Medicine
Orthopaedic surgery
663-8501 1-1 Mukogawa-cho, Nishinomiya City, Hyogo, Japan
0798-45-6111
yoshiya@hyo-med.ac.jp
Hyogo College of Medicine
None
Self funding
NO
兵庫医科大学病院
2015 | Year | 08 | Month | 29 | Day |
Published
http://dx.doi.org/10.1016/j.arth.2015.10.030
Completed
2010 | Year | 08 | Month | 05 | Day |
2010 | Year | 10 | Month | 16 | Day |
2015 | Year | 08 | Month | 29 | Day |
2016 | Year | 04 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021804